Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 
Category: Pharmacy | Geriatrics | AIDS | News

Back to Health News

HIV Drugs May Be Tied to Early Aging

Last Updated: June 26, 2011.

 

Older class of antiretroviral meds appears to damage DNA, study finds

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Older class of antiretroviral meds appears to damage DNA, study finds.

SUNDAY, June 26 (HealthDay News) -- An older class of antiretroviral drugs used to treat HIV can cause premature aging, a new study suggests.

Researchers examined muscle cells from HIV patients and found that zidovudine (AZT) and other antiviral drugs known as nucleoside analogue reverse-transcriptase inhibitors (NRTIs) damage DNA in mitochondria, the energy factories in cells.

The study is published June 26 in the journal Nature Genetics.

The finding may help explain why some HIV patients treated with antiviral drugs show advanced signs of frailty and age-related diseases such as dementia and cardiovascular disease at an early age.

"HIV clinics were seeing patients who had otherwise been successfully treated but who showed signs of being much older than their years. This was a real mystery," Professor Patrick Chinnery, a senior fellow in clinical science at the Institute of Genetic Medicine at Newcastle University in England, said in a Wellcome Trust news release.

"The DNA in our mitochondria gets copied throughout our lifetimes and, as we age, naturally accumulates errors," he explained.

"We believe that these HIV drugs accelerate the rate at which these errors build up. So over the space of, say, 10 years, a person's mitochondrial DNA may have accumulated the same amount of errors as a person who has naturally aged 20 or 30 years. What is surprising, though, is that patients who came off the medication many years ago may still be vulnerable to these changes."

Because they're relatively cheap, NRTIs are important for people in Africa and low-income countries, said study co-author and HIV specialist Dr. Brendan Payne of the Royal Victoria Infirmary in Newcastle.

"These drugs may not be perfect, but we must remember that when they were introduced they gave people an extra ten or twenty years when they would otherwise have died," Payne said in the news release. "In Africa, where the HIV epidemic has hit hardest and where more expensive medications are not an option, they are an absolute necessity."

More information

The New Mexico AIDS Education and Training Center has more about antiretroviral therapy.

SOURCE: Wellcome Trust, news release, June 26, 2011

Copyright © 2011 HealthDay. All rights reserved.


Previous: Life Expectancy Improves for Type 1 Diabetics Next: Calories, Not Protein or Carbs, Are Key to Weight Loss: Study

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.